Canada Life’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Canada Life's MRNA Position: Q3 2026 in Review
Canada Life reduced its Moderna (MRNA) stake by 0.78% in Q3 2026, selling an estimated $128K and leaving 151,038 shares worth $29M. The position accounts for 0.05% of the portfolio, ranked #293.
Canada Life first reported a position in MRNA in Q2 2020 and has held it in 26 quarters since. The position peaked at $98.5M in Q3 2021. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Canada Life held 151,038 shares of Moderna worth $29M as of Q3 2026.
- Canada Life sold 1,190 Moderna shares in Q3 2026, an estimated $128K.
- Moderna made up 0.05% of Canada Life's portfolio in Q3 2026, its #293 holding.
- Canada Life first reported a position in Moderna in Q2 2020 and has held it in 26 quarters since.
- Canada Life's Moderna position peaked at $98.5M in Q3 2021.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Canada Life's 13F filing for Q3 2026, filed 13 Nov 2026.